-
1
-
-
84995294785
-
-
Helicobacter Res 12(6): 392-398, 2008.
-
(2008)
Helicobacter Res
, vol.12
, Issue.6
, pp. 392-398
-
-
-
2
-
-
84958706509
-
-
Japanese source
-
-
-
-
3
-
-
84995275432
-
-
Helicobacter Res 5(3): 242-245, 2001.
-
(2001)
Helicobacter Res
, vol.5
, Issue.3
, pp. 242-245
-
-
-
4
-
-
0026335656
-
Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate
-
Ellman MH, Hurwitz H, Thomas C, et al: Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 18(11): 1741-1743, 1991.
-
(1991)
J Rheumatol
, vol.18
, Issue.11
, pp. 1741-1743
-
-
Ellman, M.H.1
Hurwitz, H.2
Thomas, C.3
-
5
-
-
0037020971
-
Remission of lymphoma after drug withdrawal in rheumatoid arthritis
-
Lim IG and Bertouch JV: Remission of lymphoma after drug withdrawal in rheumatoid arthritis. Med J Aust 177(9): 500-501, 2002. (Pubitemid 35373438)
-
(2002)
Medical Journal of Australia
, vol.177
, Issue.9
, pp. 500-501
-
-
Lim, I.G.S.1
Bertouch, J.V.2
-
6
-
-
33645314638
-
Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection
-
Murakami K, Sato R, Okimoto T, et al: Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection. J Gastroenterol Hepatol 21(1 Pt 2): 262-267, 2006.
-
(2006)
J Gastroenterol Hepatol
, vol.21
, Issue.1 PART 2
, pp. 262-267
-
-
Murakami, K.1
Sato, R.2
Okimoto, T.3
-
7
-
-
33644537268
-
'Rescue' therapies for the management of Helicobacter pylori infection
-
Di Mario F, Cavallaro LG and Scarpignato C: 'Rescue' therapies for the management of Helicobacter pylori infection. Dig Dis 24(1-2): 113-130, 2006.
-
(2006)
Dig Dis
, vol.24
, Issue.1-2
, pp. 113-130
-
-
Di Mario, F.1
Cavallaro, L.G.2
Scarpignato, C.3
-
8
-
-
37249090223
-
Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005
-
Kobayashi I, Murakami K, Kato M, et al: Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005. J Clin Microbiol 45(12): 4006-4010, 2007.
-
(2007)
J Clin Microbiol
, vol.45
, Issue.12
, pp. 4006-4010
-
-
Kobayashi, I.1
Murakami, K.2
Kato, M.3
-
9
-
-
84995275430
-
-
Helicobacter Res 12(5): 346-348, 2008.
-
(2008)
Helicobacter Res
, vol.12
, Issue.5
, pp. 346-348
-
-
-
10
-
-
77649186287
-
Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin
-
Gisbert JP, Pérez-Aisa A, Castro-Fernández M, et al: Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin. Dig Liver Dis 42(4): 287-290, 2010.
-
(2010)
Dig Liver Dis
, vol.42
, Issue.4
, pp. 287-290
-
-
Gisbert, J.P.1
Pérez-Aisa, A.2
Castro-Fernández, M.3
-
11
-
-
0037251258
-
Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance
-
DOI 10.1046/j.1365-2036.2003.01401.x
-
Murakami K, Sato R, Okimoto T, et al: Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance. Aliment Pharmacol Ther 17(1): 119-123, 2003. (Pubitemid 36140441)
-
(2003)
Alimentary Pharmacology and Therapeutics
, vol.17
, Issue.1
, pp. 119-123
-
-
Murakami, K.1
Sato, R.2
Okimoto, T.3
Nasu, M.4
Fujioka, T.5
Kodama, M.6
Kagawa, J.7
-
12
-
-
84995296279
-
-
Helicobacter Res 11(4): 399-402, 2007.
-
(2007)
Helicobacter Res
, vol.11
, Issue.4
, pp. 399-402
-
-
-
13
-
-
84995269525
-
-
Helicobacter pylori 44(7): 480-482, 2003.
-
(2003)
Helicobacter Pylori
, vol.44
, Issue.7
, pp. 480-482
-
-
-
14
-
-
0027935123
-
Evaluation of minocycline and cefuzonam for antimicrobial activity against clinical isolates
-
Igari J, Oguri T and Higuchi T: Evaluation of minocycline and cefuzonam for antimicrobial activity against clinical isolates. Jpn J Antibiot 47(8): 1013-1029, 1994. (Pubitemid 24275299)
-
(1994)
Japanese Journal of Antibiotics
, vol.47
, Issue.8
, pp. 1013-1029
-
-
Igari, J.1
Oguri, T.2
Higuchi, T.3
-
15
-
-
0033900316
-
Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones
-
Sánchez JE. Sáenz NG, Rincón MR, et al: Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones. J Antimicrob Chemother 46(2): 283-285, 2000.
-
(2000)
J Antimicrob Chemother
, vol.46
, Issue.2
, pp. 283-285
-
-
Sánchez, J.E.1
Sáenz, N.G.2
Rincón, M.R.3
-
16
-
-
33745910231
-
Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan
-
DOI 10.1111/j.1523-5378.2006.00415.x
-
Miyachi H, Miki I, Aoyama N, et al: Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan. Helicobacter 11(4): 243-249, 2006. (Pubitemid 44051350)
-
(2006)
Helicobacter
, vol.11
, Issue.4
, pp. 243-249
-
-
Miyachi, H.1
Miki, I.2
Aoyama, N.3
Shirasaka, D.4
Matsumoto, Y.5
Toyoda, M.6
Mitani, T.7
Morita, Y.8
Tamura, T.9
Kinoshita, S.10
Okano, Y.11
Kumagai, S.12
Kasuga, M.13
-
17
-
-
21744463045
-
A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses
-
DOI 10.1111/j.1365-2036.2005.02522.x
-
Gatta L, Zullo A, Perna F, et al: A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses. Aliment Pharmacol Ther 22(1): 45-49, 2005. (Pubitemid 40943874)
-
(2005)
Alimentary Pharmacology and Therapeutics
, vol.22
, Issue.1
, pp. 45-49
-
-
Gatta, L.1
Zullo, A.2
Perna, F.3
Ricci, C.4
De Francesco, V.5
Tampieri, A.6
Bernabucci, V.7
Cavina, M.8
Hassan, C.9
Ierardi, E.10
Morini, S.11
Vaira, D.12
-
18
-
-
84958706510
-
-
Japanese source
-
-
-
|